| |
RASSF1A
|
APC
|
MGMT
|
CDKN2A
|
CDKN2B
|
|---|
|
Invasive high grade urothelial bladder cancer (n = 33)
| | | | | |
|
Mean
|
40
|
6.1
|
9
|
0.09
|
0.58
|
|
Range
|
0-270
|
0-50
|
0-96
|
0-2
|
0-6
|
|
Non-invasive low grade urothelial bladder cancer (n = 43)
| | | | | |
|
Mean
|
2
|
2
|
2.3
|
0.4
|
0.1
|
|
Range
|
0-49
|
0-43
|
0-41
|
0-8
|
0-2
|
|
Normal bladder (n = 10)
| | | | | |
|
Mean
|
2
|
0
|
0
|
1
|
2
|
|
Range
|
0-12
|
0
|
0-4
|
0-16
|
0-1
|
|
*p-value
|
<0.001
|
<0.001
|
<0.001
|
0.748
|
0.114
|
|
Plasma samples (n = 16)
| | | | | |
|
Mean
|
24.9
|
0.035
|
16.2
|
1.5
|
5.9
|
|
Range
|
3-125
|
0-4.4
|
0.1-111.7
|
0-16.3
|
0.1-18.9
|
|
**p-value
|
0.539
|
<0.001
|
0.524
|
0.215
|
<0.01
|
- *Kruskal Wallis Test **Paired T-Test (p-value<0.01).
